Alpha-Synuclein — World Parkinson Congress Blog

Posts tagged Alpha-Synuclein

Parkinson’s Disease And Neuronal Activity: What Is The Connection?

Parkinson’s Disease And Neuronal Activity: What Is The Connection?

by Jun Ueda, MD, PhD, and Ryosuke Takahashi, MD, PhD

Basic ScienceJun Ueda, MD, PhD, and Ryosuke Takahashi, MD, PhDMay 12, 2022Parkinson's, Alpha-Synuclein, neuronal activity, perampanel, macropinocytosis, Seven Comment

Bidirectional Propagation of Alpha-Synuclein Pathology in Nonhuman Primates: New Insights Into the Gut-Brain Axis in Parkinson’s Disease

Bidirectional Propagation of Alpha-Synuclein Pathology in Nonhuman Primates: New Insights Into the Gut-Brain Axis in Parkinson’s Disease

by Dr. Erwan Bezard, PhD

Basic ScienceDr. Erwan Bezard, PhDFebruary 28, 2022Parkinson's, gut, Alpha-Synuclein, Vagus nerve, SevenComment

Clinical Alpha-Synuclein Biomarker Urgently Needed!

Clinical Alpha-Synuclein Biomarker Urgently Needed!

Thomas G Beach, MD, PhD

Basic ScienceThomas G Beach, MD, PhDJuly 6, 2021Parkinson's, Diagnosis, Alpha-Synuclein, Target engagement, Clinical Trials, Monoclonal Antibody, Biopsy, six Comment

Alpha-Synuclein Biomarker Development for PD Research

Alpha-Synuclein Biomarker Development for PD Research

by Leonidas Stefanis, MD, PhD

Clinical ScienceLeonidas Stefanis MD, PhDSeptember 21, 2018three, Alpha-Synuclein, parkinson's disease, ResearchComment

Why Have We Failed In Our Attempts To Develop A Neuroprotective Therapy For Parkinson's? How Can We Improve This Situation?

Why Have We Failed In Our Attempts To Develop A Neuroprotective Therapy For Parkinson's? How Can We Improve This Situation?

by A. Jon Stoessl CM, MD FRCPC

Clinical ScienceA. Jon Stoessl CM, MD FRCPCJune 18, 2018three, neuroprotection, Alpha-Synuclein, GBAComment

Re-purposing Old Drugs for New Treatments for Parkinson's Disease: Can an Asthma Drug Slow Progression of PD

Re-purposing Old Drugs for New Treatments for Parkinson's Disease: Can an Asthma Drug Slow Progression of PD

by John G. Nutt, MD

Clinical ScienceJohn G. Nutt, MDJanuary 31, 2018Repurposing drugs, Albuterol, Alpha-Synuclein, twoComment

Waiting and Hoping

Waiting and Hoping

by Jon Palfreman, PhD

AdvocacyJon Palfreman PhDJuly 31, 2017Disease Modification, Alpha-Synuclein, one, FirstComment

Sweeter may be Bitter for Parkinson's Disease

Sweeter may be Bitter for Parkinson's Disease

by Tiago Fleming Outiero, PhD

Basic ScienceTiago Fleming Outiero, PhDApril 24, 2017Alpha-Synuclein, Enviromental risk factors, Therapies, Parkinson's, April 2017, one, FirstComment